MTRI insider filings

InMed Pharmaceuticals Inc. — 16 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-12. Screen MTRI transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 16 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
ADAR1 Capital Management, LLC — 10% owner & Schneeberger Daniel — 10% owner11 leg · 2,640 sh · $34,572——
Bruno Julianne — Director2——1
Divis Gregory J — See Remarks, Director2——1
Hagen Brett R — See Remarks2——1
Pernice Michelle Patricia — Director2——1
Sandler Laura Lee — Director2——1
Seurer Jerad G. — See Remarks2——1
Shegog Todd — Director2——1
Fairmount Funds Management LLC — 10% owner & Fairmount Healthcare Fund II L.P. — 10% owner & Kiselak Tomas — 10% owner & Harwin Peter Evan — 10% owner1———

Recent insider filings — InMed Pharmaceuticals Inc.

FiledFormInsiderReported transactionsSource
2026-11-124Shegog Todd — DirectorGrant/award (A): 37,000 (derivative) @ $0EDGAR
2026-11-124Pernice Michelle Patricia — DirectorGrant/award (A): 37,000 (derivative) @ $0EDGAR
2026-11-124Bruno Julianne — DirectorGrant/award (A): 37,000 (derivative) @ $0EDGAR
2026-11-124Divis Gregory J — See Remarks, DirectorGrant/award (A): 1,560,599 (derivative) @ $0EDGAR
2026-11-124Hagen Brett R — See RemarksGrant/award (A): 171,000 (derivative) @ $0EDGAR
2026-11-124Sandler Laura Lee — DirectorGrant/award (A): 37,000 (derivative) @ $0EDGAR
2026-11-124Seurer Jerad G. — See RemarksGrant/award (A): 257,000 (derivative) @ $0EDGAR
2026-11-123Bruno Julianne — DirectorHoldings only — no transactions reportedEDGAR
2026-11-123Pernice Michelle Patricia — DirectorHoldings only — no transactions reportedEDGAR
2026-11-123Sandler Laura Lee — DirectorHoldings only — no transactions reportedEDGAR
2026-11-123Shegog Todd — DirectorHoldings only — no transactions reportedEDGAR
2026-11-123Fairmount Funds Management LLC — 10% owner
Fairmount Healthcare Fund II L.P. — 10% owner
Kiselak Tomas — 10% owner
Harwin Peter Evan — 10% owner
Holdings only — no transactions reportedEDGAR
2026-11-123Seurer Jerad G. — See RemarksHoldings only — no transactions reportedEDGAR
2026-11-123Hagen Brett R — See RemarksHoldings only — no transactions reportedEDGAR
2026-11-123Divis Gregory J — See Remarks, DirectorHoldings only — no transactions reportedEDGAR
2026-11-094ADAR1 Capital Management, LLC — 10% owner
Schneeberger Daniel — 10% owner
Purchase (P): 2,640 @ $13.10EDGAR

Recent 8-K events — InMed Pharmaceuticals Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-168-K2.01 — Completion of Acquisition or Disposition of Assets
2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-108-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.02 — Results of Operations and Financial Condition
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
5.06 — Change in Shell Company Status
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-038-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-228-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-108-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MTRI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs